The complaint
On November 19, 2026, Cerence Operating Company filed a complaint in the United States District Court for the District of Delaware against Eleven Labs Inc. The case is Cerence Operating Company v. Eleven Labs Inc., No. 1:26-cv-01487. The complaint says Cerence Operating Company is a wholly owned subsidiary of a Delaware corporation with its principal place of business in Burlington, Massachusetts. It alleges, on information and belief, that Eleven Labs is a Delaware corporation with its principal place of business in New York, New York. The action is brought under 35 U.S.C. 271, and the complaint demands a jury.
The five patents
The complaint says Cerence owns each of the five patents by assignment, including the right to recover damages for past, present, and future infringement. The titles and issue dates it gives are these. U.S. Patent 8,355,484, "Methods and Apparatus for Masking Latency in Text-to-Speech Systems," issued January 15, 2013. U.S. Patent 9,368,102, "Method and System for Text-to-Speech Synthesis with Personalized Voice," issued June 14, 2016. U.S. Patent 9,495,954, "System and Method of Synthetic Voice Generation and Modification," issued November 15, 2016. U.S. Patent 9,519,766, "System and Method of Providing and Validating Enhanced CAPTCHAs," issued December 13, 2016. U.S. Patent 12,477,291, "Acoustic Interference Suppression through Speaker-Aware Processing," issued November 18, 2025. The complaint states that the patents are valid and enforceable, and that Eleven Labs is not licensed under them.
The complaint says a claim chart applying an exemplary independent claim of each patent to an exemplary accused product is attached, as Exhibits F, G, H, I, and J. The claim charts are not available.
The accused products
The complaint alleges that Eleven Labs infringes at least one claim of the '484 patent through text-to-speech technology for use in its AI voice agents, which the complaint calls the ElevenAgents products, and through ElevenAPI. It alleges infringement of at least one claim of the '102 patent through the ElevenCreative platform and ElevenAPI, of the '954 patent through the ElevenAgents products, of the '766 patent through ElevenAPI and the ElevenCreative products, and of the '291 patent through the ElevenCreative products and ElevenAPI. It refers to those three as exemplary accused products.
The complaint alleges, on information and belief, that Eleven Labs develops and commercializes speech synthesis, speech-to-text, voice cloning, and conversational AI, and that it offers products and services in the United States through a website, a web-based platform, mobile applications, and application programming interfaces. It alleges, on information and belief, that those offerings are built on a common core of speech and voice AI technology. It says its infringement allegations apply to each Eleven Labs product or service that incorporates, uses, or is built on that technology, and that the three named products are identified for illustration only and without limitation.
In support of the inducement allegations, the complaint quotes Eleven Labs pages. On the '484 patent, it quotes a page describing a soft timeout that plays a brief filler phrase while a response is generated. On the '102 patent, it quotes a page that says "Create a digital replica of your voice that sounds just like you." On the '766 patent, it quotes a page stating that a verification process "uses voice-captcha technology to confirm that you are the person providing the voice samples." On the '291 patent, it quotes a page stating that a voice isolator "strips background noise from audio files for film, podcast, and interview post production."
Notice and the five counts
There are five counts, one for each patent: Count I for the '484 patent, Count II for the '102 patent, Count III for the '954 patent, Count IV for the '766 patent, and Count V for the '291 patent. Each count is titled as Eleven Labs's infringement of that patent.
The complaint states that Eleven Labs knew of the asserted patents before this lawsuit. It states that Eleven Labs knew of the '291, '102, '766, and '954 patents since at least August 12, 2026, when a notice letter informed Eleven Labs that certain accused products infringe claims of those patents. It states that Eleven Labs knew of all five patents, including the '484 patent, since at least November 18, 2026, when a second notice letter informed Eleven Labs that certain accused products infringe claims of the asserted patents. It also states that Eleven Labs knew of the patents at least as of notice of this complaint. Each count alleges, on information and belief, earlier knowledge from the letter for that patent or, at a minimum, willful blindness. Each count states that Eleven Labs's conduct was at least objectively reckless as to the risk of infringing a valid patent.
Each count alleges direct infringement under 35 U.S.C. 271(a), literally or under the doctrine of equivalents, by making, using, selling, offering for sale, or importing products in Delaware and elsewhere in the United States. The '484 count names the ElevenAgents and ElevenAPI products, the '102 count names the ElevenCreative and ElevenAPI products, the '954 count names the ElevenAgents products, the '766 count names the ElevenAPI and ElevenCreative products, and the '291 count names the ElevenCreative and ElevenAPI products. Each count also alleges, on information and belief, infringement of at least one claim.
Each count alleges, on information and belief, induced infringement under 35 U.S.C. 271(b). The complaint alleges, on information and belief, that Eleven Labs actively induced infringement, with specific intent, by encouraging and facilitating others, including distributors, partners, customers, and end users, including by disseminating, manufacturing, distributing, importing, and maintaining the accused products, and by instructing its own agents to use, import, sell, or offer the accused products for sale. It alleges that Eleven Labs took those actions knowing that the induced acts constitute infringement, either literally or under the doctrine of equivalents. Each count alleges contributory infringement under 35 U.S.C. 271(c) by selling, offering for sale, or importing the accused products, and it states that the technology is especially made or adapted for use in infringement, is a material part of the patented invention, and is not a staple article of commerce suitable for a substantial non-infringing use.
The complaint alleges that, based on its knowledge of the patents and the belief that the accused products infringe since at least as early as November 18, 2026, if not earlier by August 12, 2026 for the '291, '102, '766, and '954 patents, Eleven Labs chose to deliberately and intentionally infringe. It alleges, on information and belief, that the infringement has been and continues to be deliberate, intentional, egregious, willful, and in reckless disregard of the valid patent claims. Each count alleges, on information and belief, that infringement of that patent is and has been willful and deliberate.
Jurisdiction, venue, and relief
The complaint pleads subject matter jurisdiction under 28 U.S.C. 1331 and 1338(a). It states that Eleven Labs is a Delaware corporation and pleads personal jurisdiction on that ground, and because, it alleges, Eleven Labs has committed acts of infringement in Delaware and will continue to do so. It pleads venue under 28 U.S.C. 1391(c) and 1400(b) on the ground that Eleven Labs is a Delaware corporation. It alleges that Eleven Labs makes, uses, offers to sell, or sells the accused products in the United States, including to customers in the District of Delaware, or imports them.
The prayer asks the court to: (A) enter judgment that Eleven Labs has infringed and continues to infringe one or more claims of each patent; (B) enter judgment that the infringement is and has been willful; (C) permanently enjoin Eleven Labs, its parents, subsidiaries, affiliates, agents, servants, employees, attorneys, representatives, successors and assigns, and all others in active concert or participation with them from infringing the patents; (D) award damages of no less than a reasonable royalty, with pre-judgment and post-judgment interest and costs, under 35 U.S.C. 284; (E) treble damages for willful infringement under 35 U.S.C. 284; (F) find the case exceptional and award costs, expenses, and reasonable attorneys' fees under 35 U.S.C. 285; and (G) grant other relief the court deems proper.
What to watch next
Watch for an answer or a Rule 12 motion. The case can end at any time, including by settlement or voluntary dismissal.